ELIAS JOSEPH JABBOUR to Life Expectancy
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Life Expectancy.
Connection Strength
0.083
-
Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations. Blood. 2009 Sep 03; 114(10):2037-43.
Score: 0.083